Zobrazeno 1 - 10
of 47
pro vyhledávání: '"JoongKee Min"'
Autor:
Jeonghyeon Seo, Hyojune Kim, Joongkee Min, Yongwoo Kim, In-Ho Jeon, Darry D’Lima, Kyoung Hwan Koh
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 18, Iss 1, Pp 1-9 (2023)
Abstract Background The minipig has been used for research in various fields of medicine, even in orthopedics. Though previous studies have already suggested other methods to create osteoporotic bone, those methods had some disadvantages for taking t
Externí odkaz:
https://doaj.org/article/ace406d377e04bb08cdbf919eed193ae
Autor:
Jae-Im Kwon, Hwon Heo, Yeon Ji Chae, Joongkee Min, Do-Wan Lee, Sang Tae Kim, Monica Young Choi, Yu Sub Sung, Kyung Won Kim, Yoonseok Choi, Dong Cheol Woo, Chul-Woong Woo
Publikováno v:
Heliyon, Vol 9, Iss 5, Pp e15596- (2023)
Aryl hydrocarbon receptors (AhRs) have been reported to be important mediators of ischemic injury in the brain. Furthermore, the pharmacological inhibition of AhR activation after ischemia has been shown to attenuate cerebral ischemia-reperfusion (IR
Externí odkaz:
https://doaj.org/article/53adcb21936b45fd87c3b4888542de0e
Autor:
Jin Kyung Rho, Jae Cheol Lee, Chang-Min Choi, Wonjun Ji, Rajesh Rengasamy, Jae-Sun Kim, Hyung Chul Ryu, Yun Jeong Kong, Sunho Lee, Sung-Eun Kim, Dong-Cheol Woo, Joongkee Min, Jeongin Cho, Chae Won Lee, Hyeonjeong Lee, Kyungtaek Im, Dong Ha Kim, Young Hoon Sung, Da-Som Kim, Yun Jung Choi
Supplementary Data from The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02–011 Overcomes C797S-Mediated Resistance in Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c72e40a980b20a6f9965cf58c368e86
https://doi.org/10.1158/0008-5472.22431839
https://doi.org/10.1158/0008-5472.22431839
Autor:
Jin Kyung Rho, Jae Cheol Lee, Chang-Min Choi, Wonjun Ji, Rajesh Rengasamy, Jae-Sun Kim, Hyung Chul Ryu, Yun Jeong Kong, Sunho Lee, Sung-Eun Kim, Dong-Cheol Woo, Joongkee Min, Jeongin Cho, Chae Won Lee, Hyeonjeong Lee, Kyungtaek Im, Dong Ha Kim, Young Hoon Sung, Da-Som Kim, Yun Jung Choi
Osimertinib is an irreversible third-generation EGFR tyrosine kinase inhibitor (TKI) that was initially developed to overcome the EGFR T790M mutation and is used as a standard therapy in patients with advanced non–small cell lung cancer (NSCLC) wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adf0914a53516f4d5a152b844ddcf7e2
https://doi.org/10.1158/0008-5472.c.6514004.v1
https://doi.org/10.1158/0008-5472.c.6514004.v1
Autor:
Jin Kyung Rho, Jae Cheol Lee, Chang-Min Choi, Wonjun Ji, Rajesh Rengasamy, Jae-Sun Kim, Hyung Chul Ryu, Yun Jeong Kong, Sunho Lee, Sung-Eun Kim, Dong-Cheol Woo, Joongkee Min, Jeongin Cho, Chae Won Lee, Hyeonjeong Lee, Kyungtaek Im, Dong Ha Kim, Young Hoon Sung, Da-Som Kim, Yun Jung Choi
Supplementary Table from The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02–011 Overcomes C797S-Mediated Resistance in Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::440dc418e274060ef1f59258e3aa59d8
https://doi.org/10.1158/0008-5472.22431836
https://doi.org/10.1158/0008-5472.22431836
Autor:
Ji Yeon Kim, Sang Ryong Jeon, Je Hoon Jeong, Jung-Mo Yang, Jun-Sub Kim, Eun-Sun Jin, Kyoung Hyo Choi, JoongKee Min, Gi-Seong Moon
Publikováno v:
Journal of Korean Neurosurgical Society. 65:204-214
Objective : Osteoporosis result from age-related decline in the number of osteoblast progenitors in the bone marrow. Probiotics have beneficial effects on the host, when administered in appropriate amounts. This study investigated the effects of prob
Autor:
Eun-Sun Jin, Je Hoon Jeong, Joongkee Min, Minsu Lee, Kyoung Hyo Choi, Ji Yeon Kim, Sang Ryong Jeon
Publikováno v:
Journal of Orthopaedic Research. 40:1321-1328
The purpose of this study was to determine the efficacy of highly concentrated tricalcium phosphate (TCP) biocomposite screws on local bone formation in a rabbit model of osteoporosis induced by bilateral ovariohysterectomy (OHE). Fourteen 24-week-ol
Autor:
Da-Som Kim, Wonjun Ji, Dong Ha Kim, Yun Jung Choi, Kyungtaek Im, Chae Won Lee, Jeongin Cho, Joongkee Min, Dong-Cheol Woo, Chang-Min Choi, Jae Cheol Lee, Young Hoon Sung, Jin Kyung Rho
Publikováno v:
Biochemical and biophysical research communications. 632
Although epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have shown dramatic response and improvement in treating lung cancer with mutant EGFR, the emergence of drug resistance remains a major problem. In particular, some mu
Autor:
Yun Jung Choi, Da-Som Kim, Young Hoon Sung, Dong Ha Kim, Kyungtaek Im, Hyeonjeong Lee, Chae Won Lee, Jeongin Cho, Joongkee Min, Dong-Cheol Woo, Sung-Eun Kim, Sunho Lee, Yun Jeong Kong, Hyung Chul Ryu, Jae-Sun Kim, Rajesh Rengasamy, Wonjun Ji, Chang-Min Choi, Jae Cheol Lee, Jin Kyung Rho
Publikováno v:
Cancer research.
Osimertinib is an irreversible third-generation EGFR tyrosine kinase inhibitor (TKI) that was initially developed to overcome the EGFR T790M mutation and is used as a standard therapy in patients with advanced non–small cell lung cancer (NSCLC) wit
Autor:
Jeong Hoon Kim, Hyung Ho Yoon, Heuiran Lee, Seong Who Kim, Sang Ryong Jeon, Hyang Ju Lee, Jin Hoon Park, Joongkee Min, Ji Hyun Kim
Publikováno v:
Journal of Korean Neurosurgical Society
Objective : Through our previous clinical trials, the demonstrated therapeutic effects of MSC in chronic spinal cord injury (SCI) were found to be not sufficient. Therefore, the need to develop stem cell agent with enhanced efficacy is increased. We